Cyclooxygenase-2 upregulation as a perigenetic change in carcinogenesis

Journal of Experimental and Clinical Cancer Research

Volumn 20, Issue 1, 2001, Pages 117-129

  Tsuji, S ^a   Tsujii, M ^a   Kawano, S ^a   Hori, M ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Angiogenesis; bFGF; Cyclooxygenase; Prostaglandin; TGF ; Tumor immunology; VEGF

Indexed keywords

CYCLOOXYGENASE 2; FIBROBLAST GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN;

APOPTOSIS; ARTICLE; CANCER GROWTH; CARCINOGENESIS; ENZYME REGULATION; HOST RESISTANCE; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; MALIGNANT TRANSFORMATION; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; ONCOGENE RAS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; TUMOR IMMUNOLOGY; VASCULAR ENDOTHELIUM;

ANIMALS; CYCLOOXYGENASE 2; CYTOKINES; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GROWTH SUBSTANCES; HELICOBACTER INFECTIONS; HUMANS; INFLAMMATION; ISOENZYMES; MEMBRANE PROTEINS; NEOPLASMS; ONCOGENES; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; STOMACH NEOPLASMS;

EID: 0035013596     PISSN: 03929078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (115)

1. Excess risk of lymphomas, leukemia and myeloma in patients with rheumatoid arthritis
2. Identification of candidate cancer chemopreventive agents and their evaluation in animal models and human clinical trials: A review
3. Aspirin use and risk of fatal cancer
4. Incidence of cancer among patients with rheumatoid arthritis
5. NSAID use and decreased risk of gastrointestinal cancers
6. TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue
7. Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing
8. Structure of the mitogen-inducible TIS10 gene and demonstration that the TIS10-encoded protein is a functional prostaglandin G/H synthase
9. Human cyclooxygenase-2 cDNA
10. cDNA cloning and functional activity of a glucocorticoid-regulated inflammatory cyclooxygenase
11. Molecular cloning of human prostaglandin endoperoxide synthase type II and demonstration of expression in response to cytokines
12. Cloning two isoforms of rat cyclooxygenase: Differential regulation of their expression
13. Cloning and characterization of a growth factor-inducible cyclooxygenase gene from rat intestinal epithelial cells
14. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas
15. Expression of cyclooxygenase-1 and -2 in human colorectal cancer
16. Expression of cyclooxygenase-2 in human gastric carcinoma
17. Cyclooxygenase- 2 overexpression enhances lymphatic invasion and metastasis in human gastric carcinoma
18. Combarison of seven cell lines derived from human gastric carcinomas
19. Evidences for involvement of cyclooxygenase-2 in proliferation of two gastrointestinal cancer cell lines
20. Patients with adenomatous polyps and carcinomas have increased colonic mucosal prostaglandin E2
21. NSA1Ds, cox-2 inhibitors, and the gut
22. Prostaglandin endoperoxide synthase: Why two isoforms?
23. Cyclooxygenase, NSA1Ds, and colorectal cancer
24. Function and regulation of prostaglandin synthase-2
25. Nonsteroidal anti-infiammatory drugs and colorectal cancer: Evolving concepts of their chemopreventive actions
26. Cyclooxygenase-2: The future is now
27. A genetic model for colorectal tumorigenesis
28. Induction of cyclooxygenase-2 by activated Ha-ras oncogene in Rat-1 fibroblasts and the role of mitogen-activated protein kinase pathway
29. A selective cyclooxygenase 2 inhibitor suppresses the growth of H-ras-transformed rat intestinal epithelial cells
30. Elevated cyclooxygenase-2 levels in Min mouse adenomas
31. Suppression of intestinal polyposis in APCDelta 716 knockout mouse by inhibition of cyclooxygenase 2 (COX-2)
32. Morphological and molecular processes of polyp formation in Apc(delta716) knockout mice
33. Large intestine and anus
34. Growth patterns and genetic changes of colorectal carcinoma
35. Activating SRC mutation in a subset of advanced human colon cancers
36. Prostaglandin G/H synthase isoenzyme 2 expression in fibroblasts: Regulation by dexamethasone, mitogens, and oncogenes
37. v-src induces prostaglandin synthase 2 gene expression by activation of the c-Jun N-terminal kinase and the c-Jun transcription factor
38. Molecular mechanism of human stomach carcinogenesis implicated in Helicobacter pylori infection
39. Cancer-stromal interaction through growth factor/cytokine networks implicated in growth of stomach cancer
40. Helicobacter pylori infection induces cyclooxygenase-2 expression in human gastric mucosa
41. Helicobacter pylori up-regulates cyclooxygenase-2 mRNA expression and prostaglandin E2 synthesis in MKN 28 gastric mucosal cells in vitro
42. Increased expression and cellular localization of inducible nitric oxide synthase and cyclooxygenase 2 in Helicobacter pylori gastritis
43. Clonal analysis of isolated intestinal metaplastic glands of stomach using X linked polymorphism
44. Increased expression of inducible nitric oxide synthase and cvclooxygenase-2 in Barrett's esophagus and associated adenocarcinomas
45. Dihydroxy bile acids activate the transcription of cyclooxygenase-2
46. Transcription of cyclooxygenase-2 is enhanced in transformed mammary epithelial cells
47. Induction of cyclooxygenase-2 expression by peroxisome proliferators and non-tetradecanoylphorbol 12,13-myristate-type tumor promotcrs in immortalized mouse liver cells
48. Characterization of the human gene (PTGS2) encoding prostaglandin-endoperoxide synthase 2
49. A conserved AU sequence from the 3′ untranslated region of GM-CSF mRNA mediates selective mRNA degradation
50. Degradation of mRNA in eukaryotes
51. Down-regulation of cytokine-induced cyclo-oxygenase-2 transcript isoforms by dexamethasone: Evidence for post-transcriptional regulation
52. Multiple instability-regulating sites in the 3′ untranslated region of the urokinse-type plasminogen activator mRNA
53. Functional coupling between various phospholipase A2s and cyclooxygenases in immediate and delayed prostanoid biosynthetic pathways
54. Segregated coupling of phospholipases A2, cyclooxygenases, and terminal prostanoid synthases in different phases of prostanoid biosynthesis in rat peritoneal macrophages
55. Effect of prostaglandin E in multiple experimental models. VIII. Effect on host response to metastatic tumor
56. Activators of the nuclear receptor PPARgamma enhance colon polyp formation
57. Activation of the peroxisome proliferator-activated receptor gamma promores the development of colon tumors in C57BL/6J-APCMin/+ mice
58. Differentiation and reversal of malignant changes in colon cancer through PPARgamma
59. Feedback control of cyclooxygenase-2 expression through PPARgamma
60. PPARdelta is an APC-regulated target of nonsteroidal anti-inflammatory drugs
61. Expression-activity profiles of cells transfected with prostaglandin endoperoxide H synthase measured by quantitative fluorescence microscopy
62. Redox regulation of cellular signalling
63. Biological aspects of reactive nitrogen species
64. Interaction of cyclooxygenases with an apoptosis- and autoimmunity-associated protein
65. The mammalian calcium-binding protein, nucleobindin (CALNUC), is a Golgi resident protein
66. Antigen expression associated with lymph node metastasis in gastric adenocarcinomas
67. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2
68. G1 delay in cells overexpressing prostaglandin endoperoxide synthase-2
69. Modulation of apoptosis and Bcl-2 expression by prostaglandin E2 in human colon cancer cells
70. Overexpression of cyclooxygenase-2 induces cell cycle arrest. Evidence for a prostaglandin-independent mechanism
71. Involvement of cyclooxygenase-2 in proliferation and morphogenesis induced by transforming growth factor alpha in gastric epithelial cells
72. Epithelial stem cells in gastrointestinal morphogenesis, adaptation and carcinogenesis
73. Identification of a metaplastic cell lineage associated with human gastric adenocarcinoma
74. Crypt fission in the small intestine and colon. A mechanism for the emergence of G6PD locus-mutated crypts after treatment with mutagens
75. Polyclonal origin of colonic adenomas in an XO/XY patient with FAP
76. APC in the regulation of intestinal crypt fission
77. Origins and morphogenesis of colorectal neoplasms
78. Repair of gastric ulcer. A cell kinetic study
79. Induction of a novel epidermal growth factor-secreting cell lineage by mucosal ulceration in human gastrointestinal stem cells
80. The migration pathway of epithelial cells on human duodenal villi: The origin and fate of 'gastric metaplastic' cells in duodenal mucosa
81. Aspects of the biology of regeneration and repair in the human gastrointestinal tract
82. Effect of cellular aging on the induction of cyclooxygenase-2 by mechanical stress in human periodontal ligament cells
83. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis
84. Intestinal polyposis in mice with a dominant stable mutation of the beta-catenin gene
85. Cyclooxygenase 2 expression is increased in the stroma of colon carcinomas from IL-10 -/- mice
86. High expression ofcyclooxygenase-2 in macrophages of human colonic adenoma
87. Localization of cyclooxygenase-2 in human sporadic colorectal adenomas
88. Host cyclooxygenase-2 modulates carcinoma growth
89. Effect of cyclooxygenase (COX)-1 and -2 expression on VEGF and HGF production in fibroblasts
90. How is blood vessel growth regulated in normal and neoplastic tissue? G.H.A. CIowes memorial award lecture
91. Tumor angiogenesis and metastasis - Correlation in invasive breast carcinoma
92. Angiogenesis
93. Effects of angiogenesis inhibitors on multistage carcinogenesis in mice
94. Cyclooxygenase regulates angiogenesis induced by colon cancer cells
95. Cyclooxygenase-2 inhibitors suppress the growth of gastric cancer xenografts via induction of apoptosis in nude mice
96. Effects of NSAIDs on proliferation of gastric cancer cells in vitro: Possible implication of cyclooxygenase-2 in cancer development
97. Cyclooxygenase inhibitors suppress angiogenesis and reduce tumor growth in vivo
98. Tumor induction of VEGF promoter activity in stromal cells
99. Induction of vascular endothelial growth factor expression by prostaglandin E2 and E1 in osteoblasts
100. Prostaglandin E2 induces vascular endothelial growth factor and basic fibroblast growth factor mRNA expression in cultured rat Mueler cells
101. Induction of vascular endothelial growth factor expression in synovial fibroblasts by prostaglandin E and interleukin-I: A potential mechanism for inflammatory angiogenesis
102. Vascular endothelial growth factor signals endothelial cell production of nitric oxide and prostacyclin through flk-1/KDR activation of c-Src
103. Thromboxane A2 is a mediator of cyclooxygenase-2-dependent endothelial migration and angiogenesis
104. Comparison of the effects of immunosuppressive factors from newly established colon carcinoma cell cultures on human lymphocyte proliferation and cytokine secretion
105. Biphenotypic B/macrophage cells express COX-1 and up-regulate COX-2 expression and prostaglandin E(2) production in response to pro-inflammatory signals
106. Prostaglandin E production by human blood monocytes and mouse peritoneal macrophages
107. Release of leukotrienes C4 and B4 and prostaglandin E2 from human monocytes stimulated with aggregated IgG, IgA, and IgE
108. Synergistic stimulation of fibroblast prostaglandin production by recombinant interleukin 1 and tumor necrosis factor
109. Regulation of B-cell tolerance and triggering by macrophages and lymphoid dendritic cells
110. Prostaglandin E 2 inhibits production of Th1 lymphokines but not of Th2 lymphokines
111. The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation
112. A novel therapy for colitis utilizing PPAR-gamma ligands to inhibit the epithelial inflammatory response
113. The nuclear receptor PPAR gamma and immunoregulation: PPAR gamma mediates inhibition of helper T cell responses
114. Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of 1kappaB kinase
115. Arthritis drug approved for polyp prevention blazes trail for other prevention trials